AUR-107
/ Dr. Reddy’s
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 31, 2024
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
(clinicaltrials.gov)
- P1 | N=50 | Recruiting | Sponsor: Aurigene Discovery Technologies Limited | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor • MUC16
May 18, 2023
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
(clinicaltrials.gov)
- P1 | N=50 | Not yet recruiting | Sponsor: Aurigene Discovery Technologies Limited
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1